These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
300 related articles for article (PubMed ID: 35460628)
21. Cervical pessary versus vaginal progesterone in women with a singleton pregnancy, a short cervix, and no history of spontaneous preterm birth at less than 34 weeks' gestation: open label, multicentre, randomised, controlled trial. van Dijk CE; van Gils AL; van Zijl MD; Koullali B; van der Weide MC; van den Akker ES; Hermsen BJ; van Baal WM; Visser H; van Drongelen J; Vollebregt KC; Muller M; van der Made FW; Gordijn SJ; de Mooij YM; Oudijk MA; de Boer MA; Mol BW; Kazemier BM; Pajkrt E; BMJ; 2024 Mar; 384():e077033. PubMed ID: 38471724 [TBL] [Abstract][Full Text] [Related]
23. Concurrent progestogen and cerclage to reduce preterm birth: a multicenter international retrospective cohort. Tolosa JE; Boelig RC; Bell J; Martínez-Baladejo M; Stoltzfus J; Mateus J; Quiñones JN; Galeano-Herrera S; Pereira L; Burwick R; López-Torres L; Valencia C; Berghella V; Am J Obstet Gynecol MFM; 2024 Jul; 6(7):101351. PubMed ID: 38513806 [TBL] [Abstract][Full Text] [Related]
24. Vaginal progesterone pessaries for pregnant women with a previous preterm birth to prevent neonatal respiratory distress syndrome (the PROGRESS Study): A multicentre, randomised, placebo-controlled trial. Crowther CA; Ashwood P; McPhee AJ; Flenady V; Tran T; Dodd JM; Robinson JS; PLoS Med; 2017 Sep; 14(9):e1002390. PubMed ID: 28949973 [TBL] [Abstract][Full Text] [Related]
25. Early vaginal progesterone versus placebo in twin pregnancies for the prevention of spontaneous preterm birth: a randomized, double-blind trial. Rehal A; Benkő Z; De Paco Matallana C; Syngelaki A; Janga D; Cicero S; Akolekar R; Singh M; Chaveeva P; Burgos J; Molina FS; Savvidou M; De La Calle M; Persico N; Quezada Rojas MS; Sau A; Greco E; O'Gorman N; Plasencia W; Pereira S; Jani JC; Valino N; Del Mar Gil M; Maclagan K; Wright A; Wright D; Nicolaides KH Am J Obstet Gynecol; 2021 Jan; 224(1):86.e1-86.e19. PubMed ID: 32598909 [TBL] [Abstract][Full Text] [Related]
26. Techniques of monitoring blood glucose during pregnancy for women with pre-existing diabetes. Moy FM; Ray A; Buckley BS; West HM Cochrane Database Syst Rev; 2017 Jun; 6(6):CD009613. PubMed ID: 28602020 [TBL] [Abstract][Full Text] [Related]
27. Combined vaginal progesterone and cervical cerclage in the prevention of preterm birth: a systematic review and meta-analysis. Aubin AM; McAuliffe L; Williams K; Issah A; Diacci R; McAuliffe JE; Sabdia S; Phung J; Wang CA; Pennell CE Am J Obstet Gynecol MFM; 2023 Aug; 5(8):101024. PubMed ID: 37211087 [TBL] [Abstract][Full Text] [Related]
28. Vaginal progesterone, oral progesterone, 17-OHPC, cerclage, and pessary for preventing preterm birth in at-risk singleton pregnancies: an updated systematic review and network meta-analysis. Jarde A; Lutsiv O; Beyene J; McDonald SD BJOG; 2019 Apr; 126(5):556-567. PubMed ID: 30480871 [TBL] [Abstract][Full Text] [Related]
29. Cervical cerclage for short cervix at 24 to 26 weeks of gestation: systematic review and meta-analysis of randomized controlled trials using individual patient-level data. Gulersen M; Lenchner E; Nicolaides KH; Otsuki K; Rust OA; Althuisius S; Bornstein E; Berghella V Am J Obstet Gynecol MFM; 2023 Jun; 5(6):100930. PubMed ID: 36924844 [TBL] [Abstract][Full Text] [Related]
30. Nonresponse to 17-alpha hydroxyprogesterone caproate for recurrent spontaneous preterm birth prevention: clinical prediction and generation of a risk scoring system. Manuck TA; Stoddard GJ; Fry RC; Esplin MS; Varner MW Am J Obstet Gynecol; 2016 Nov; 215(5):622.e1-622.e8. PubMed ID: 27418444 [TBL] [Abstract][Full Text] [Related]
31. Treating periodontal disease for preventing adverse birth outcomes in pregnant women. Iheozor-Ejiofor Z; Middleton P; Esposito M; Glenny AM Cochrane Database Syst Rev; 2017 Jun; 6(6):CD005297. PubMed ID: 28605006 [TBL] [Abstract][Full Text] [Related]
32. A chronicle of the 17-alpha hydroxyprogesterone caproate story to prevent recurrent preterm birth. Nelson DB; McIntire DD; Leveno KJ Am J Obstet Gynecol; 2021 Feb; 224(2):175-186. PubMed ID: 33035472 [TBL] [Abstract][Full Text] [Related]
33. Progestogens in singleton gestations with preterm prelabor rupture of membranes: a systematic review and metaanalysis of randomized controlled trials. Quist-Nelson J; Parker P; Mokhtari N; Di Sarno R; Saccone G; Berghella V Am J Obstet Gynecol; 2018 Oct; 219(4):346-355.e2. PubMed ID: 29614278 [TBL] [Abstract][Full Text] [Related]
34. Meta-analysis of randomized controlled trials comparing 17α-hydroxyprogesterone caproate and vaginal progesterone for the prevention of recurrent spontaneous preterm delivery. Oler E; Eke AC; Hesson A Int J Gynaecol Obstet; 2017 Jul; 138(1):12-16. PubMed ID: 28369874 [TBL] [Abstract][Full Text] [Related]
36. Intramuscular progesterone in women with twins and a prior singleton spontaneous preterm birth. Ward A; Greenberg V; Valcarcel B; Boelig RC; Al-Kouatly HB; Berghella V Am J Obstet Gynecol MFM; 2020 Aug; 2(3):100124. PubMed ID: 33345870 [TBL] [Abstract][Full Text] [Related]
37. Gestational diabetes mellitus and adverse maternal and perinatal outcomes in twin and singleton pregnancies: a systematic review and meta-analysis. Greco E; Calanducci M; Nicolaides KH; Barry EVH; Huda MSB; Iliodromiti S Am J Obstet Gynecol; 2024 Feb; 230(2):213-225. PubMed ID: 37595821 [TBL] [Abstract][Full Text] [Related]